Bright Minds Biosciences Inc.
DRUG
CNSX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 57.98% | -2.74% | -3.73% | 850.34% | -6.39% |
| Total Receivables | 48.37% | 23.02% | 248.71% | 25.27% | 195.24% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 36.56% | 85.96% | 55.77% | 11.78% | 276.53% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 57.64% | -2.00% | -3.17% | 813.06% | -3.20% |
|
|
|||||
| Total Current Assets | 57.64% | -2.00% | -3.17% | 813.06% | -3.20% |
| Net Property, Plant & Equipment | -15.01% | -12.00% | -12.60% | 41.22% | 889.77% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 57.46% | -2.02% | -3.20% | 798.21% | -1.49% |
|
|
|||||
| Total Accounts Payable | 227.88% | -2.35% | 47.67% | -13.92% | 176.03% |
| Total Accrued Expenses | 3,217.09% | 85.71% | -40.57% | -65.70% | 180.91% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 5.93% | 5.91% | 7.13% | -14.12% | 476.47% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 277.95% | -0.05% | 38.34% | -18.02% | 199.85% |
|
|
|||||
| Total Current Liabilities | 277.95% | -0.05% | 38.34% | -18.02% | 199.85% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -35.79% | -25.40% | -19.22% | 161.09% | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 248.42% | -3.16% | 27.28% | -5.54% | 222.30% |
|
|
|||||
| Common Stock & APIC | 34.22% | 5.41% | 1.09% | 135.95% | 2.40% |
| Retained Earnings | -7.33% | -20.22% | -8.71% | 6.24% | -3.64% |
| Treasury Stock & Other | 19.24% | 50.13% | -0.20% | -34.63% | -2.32% |
| Total Common Equity | 55.00% | -2.01% | -3.50% | 880.70% | -8.04% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 55.00% | -2.01% | -3.50% | 880.70% | -8.04% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.00% | -2.01% | -3.50% | 880.70% | -8.04% |
|
|
|||||